Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.

@article{Seynaeve2004IpsilateralBT,
  title={Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.},
  author={Caroline M. Seynaeve and Leon C. Verhoog and L M C van de Bosch and Albert N. van Geel and Marian B. E. Menke-Pluymers and Elizabeth J Meijers-Heijboer and Ans M. W. van den Ouweland and Andrea Veiga Wagner and Carien L. Creutzberg and Martinus F. Niermeijer and Jan G. M. Klijn and Cecile T. M. Brekelmans},
  journal={European journal of cancer},
  year={2004},
  volume={40 8},
  pages={1150-8}
}
The overall rate of an ipsilateral breast tumour recurrence (IBTR) after breast-conserving therapy (BCT) ranges from 1% to 2% per year. Risk factors include young age but data on the impact of BRCA1/2 mutations or a definite positive family history for breast cancer are scarce. We investigated IBTR after BCT in patients with hereditary breast cancer (HBC… CONTINUE READING